Lycopene and Beta-carotene Metabolism in the Digestive Tract of Healthy Men

NCT03492593 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-04-10

No results posted yet for this study

Summary

Consumption of foods containing carotenoids, as well as vitamin E, have been associated with lower risk of developing a number of chronic diseases. While the parent compounds have largely been assumed to exert protective antioxidant effects, more recent work has suggested that metabolites may be bioactive. Very little attention has been given to the metabolism of these compounds during the digestive process. Our primary aim is to conduct a postprandial feeding study in healthy men to determine the stability of carotenoids and vitamin E during digestion, and to identify the primary metabolites produced in various compartments of the upper gastrointestinal tract and blood during digestion. Targeted metabolites will be identified and quantitated using high-performance liquid chromatography-tandem mass spectrometry methods previously developed. In addition, a non-targeted metabolomics approach will be used to identify non-predicted metabolites in the samples. A better understanding of carotenoid and vitamin E stability and metabolism during digestion will provide greater insight into how these compounds may confer protection against chronic disease.

Conditions

  • Digestion Chambers
  • Stability and Metabolism of Carotenoids and Vitamin E

Interventions

OTHER

lycopene

A tomato oleoresin containing lycopene

OTHER

beta-carotene

13C beta-carotene

OTHER

control

emulsified liquid meal alone

Sponsors & Collaborators

  • Aix Marseille Université

    collaborator OTHER
  • Hôpital de la Conception

    collaborator UNKNOWN
  • Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

    lead OTHER

Principal Investigators

  • Patrick Borel, PhD · INRA/INSERM/Université Aix-Marseille

  • Catherine Caris-Veyrat · INRA/Université d'Avignon

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03492593 on ClinicalTrials.gov